Specialty R&D

We are developing products targeting important medical needs

Our Specialty Pharma business, currently operating as Impax and Gemini, delivers medicines focused on meeting important medical needs across therapeutic categories, including central nervous system disorders, endocrinology, parasitic infections and other therapeutic areas.

We are focused on the continued growth and expansion of our product portfolio through internal development as well as through acquisitions and late-stage and next-generation product partnership opportunities.

Clinical Activities

*As of May 2018